LLY•benzinga•May 21, 2024 at 12:06 PM

More Than One-Half Of Patients With Crohn's Disease Treated With Lilly's mirikizumab Achieved Clinical Remission At One Year, Including Patients With Previous Biologic Failure

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 21, 2024 by benzinga